Helperby Secures 75 Million Capital Commitment from GEM as Company Seeks to Go Public
Monday 17 March, 2025 Helperby Therapeutics Group Limited (“Helperby”) is a private pharmaceutical company focussed on developing multiple new antibiotic products to counter the global spread of Anti Microbial Resistance (“AMR”). Helperby has signed an agreement with GEM Global Yield LLC SCS (“GEM”), a Luxembourg-based private alternative investment group for an investment of up to
Monday 17 March, 2025
Helperby Therapeutics Group Limited (“Helperby”) is a private pharmaceutical company focussed on developing multiple new antibiotic products to counter the global spread of Anti Microbial Resistance (“AMR”). Helperby has signed an agreement with GEM Global Yield LLC SCS (“GEM”), a Luxembourg-based private alternative investment group for an investment of up to $75 million within 3 years of any public listing…
Read More
About Author
